Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage
Conditions: Intracerebral Hemorrhage Interventions: Drug: Fingolimod Sponsors: Tang-Du Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Czech Pharmaco-epidemiological Study on Disease Modifying Drugs
Condition: Multiple Sclerosis Intervention: Drug: interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab Sponsor: IMPULS Endowment Fund Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials
A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Condition: Multiple Sclerosis Interventions: Drug: Diroximel Fumarate; Biological: Alemtuzumab; Drug: Fingolimod; Drug: Glatiramer acetate; Biological: Interferon beta; Biological: Natalizumab; Biological: Ocrelizumab; Biological: Peginterferon beta-1a; Drug: Siponimod Sponsor: Biogen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2023 Category: Research Source Type: clinical trials
